JP2009543799A5 - - Google Patents

Download PDF

Info

Publication number
JP2009543799A5
JP2009543799A5 JP2009519632A JP2009519632A JP2009543799A5 JP 2009543799 A5 JP2009543799 A5 JP 2009543799A5 JP 2009519632 A JP2009519632 A JP 2009519632A JP 2009519632 A JP2009519632 A JP 2009519632A JP 2009543799 A5 JP2009543799 A5 JP 2009543799A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
amount
methoxy
furfuryl
disubstituted purine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009519632A
Other languages
English (en)
Japanese (ja)
Other versions
JP5309023B2 (ja
JP2009543799A (ja
Filing date
Publication date
Priority claimed from US11/774,652 external-priority patent/US20080009508A1/en
Application filed filed Critical
Publication of JP2009543799A publication Critical patent/JP2009543799A/ja
Publication of JP2009543799A5 publication Critical patent/JP2009543799A5/ja
Application granted granted Critical
Publication of JP5309023B2 publication Critical patent/JP5309023B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009519632A 2006-07-10 2007-07-10 6,9−二置換プリン誘導体および皮膚を処置するためのその使用 Expired - Fee Related JP5309023B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US80687106P 2006-07-10 2006-07-10
US60/806,871 2006-07-10
US11/774,652 2007-07-09
US11/774,652 US20080009508A1 (en) 2006-07-10 2007-07-09 6,9-Disubstituted Purine Derivatives And Their Use For Treating Skin
PCT/US2007/073142 WO2008008770A2 (en) 2006-07-10 2007-07-10 6, 9-disubstituted purine derivatives and their use for treating skin

Publications (3)

Publication Number Publication Date
JP2009543799A JP2009543799A (ja) 2009-12-10
JP2009543799A5 true JP2009543799A5 (https=) 2010-09-09
JP5309023B2 JP5309023B2 (ja) 2013-10-09

Family

ID=38919793

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009519632A Expired - Fee Related JP5309023B2 (ja) 2006-07-10 2007-07-10 6,9−二置換プリン誘導体および皮膚を処置するためのその使用

Country Status (16)

Country Link
US (4) US20080009508A1 (https=)
EP (1) EP2043630B1 (https=)
JP (1) JP5309023B2 (https=)
KR (1) KR101478727B1 (https=)
CN (1) CN101646435B (https=)
AU (1) AU2007272576B2 (https=)
BR (1) BRPI0714161A2 (https=)
CA (1) CA2657516C (https=)
EA (1) EA015848B1 (https=)
ES (1) ES2603216T3 (https=)
IL (1) IL196442A (https=)
MX (1) MX2009000347A (https=)
MY (1) MY158100A (https=)
NO (1) NO20090598L (https=)
NZ (1) NZ574711A (https=)
WO (1) WO2008008770A2 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7960397B2 (en) * 2007-12-28 2011-06-14 Institute Of Experimental Botany, Academy Of Sciences Of The Czech Republic 6,9-disubstituted purine derivatives and their use as cosmetics and cosmetic compositions
KR101763656B1 (ko) 2009-06-29 2017-08-01 인사이트 홀딩스 코포레이션 Pi3k 저해물질로서의 피리미디논
TW201130842A (en) * 2009-12-18 2011-09-16 Incyte Corp Substituted fused aryl and heteroaryl derivatives as PI3K inhibitors
US8759359B2 (en) * 2009-12-18 2014-06-24 Incyte Corporation Substituted heteroaryl fused derivatives as PI3K inhibitors
EP2558463A1 (en) 2010-04-14 2013-02-20 Incyte Corporation Fused derivatives as i3 inhibitors
EP2395086A1 (en) * 2010-06-09 2011-12-14 Chanel Parfums Beauté Inhibitors of micro-RNAs for use for preventing and/or attenuating skin ageing and/or for hydrating skin
JP5886278B2 (ja) * 2010-06-09 2016-03-16 シャネル パフュームズ ビューテ 皮膚の加齢を防止および/もしくは減弱し、並びに/または皮膚に潤いを与えるのに用いるためのマイクロrna阻害剤
WO2011163195A1 (en) 2010-06-21 2011-12-29 Incyte Corporation Fused pyrrole derivatives as pi3k inhibitors
EP3660016A1 (en) 2010-12-20 2020-06-03 Incyte Holdings Corporation N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines as pi3k inhibitors
US9108984B2 (en) 2011-03-14 2015-08-18 Incyte Corporation Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors
WO2012135009A1 (en) 2011-03-25 2012-10-04 Incyte Corporation Pyrimidine-4,6-diamine derivatives as pi3k inhibitors
PT3513793T (pt) 2011-09-02 2021-05-10 Incyte Holdings Corp Heterociclilaminas como inibidores de pi3k
US20130072506A1 (en) 2011-09-16 2013-03-21 Lenka ZAHAJSKA 6,8-disubstituted purine compositions
AR090548A1 (es) 2012-04-02 2014-11-19 Incyte Corp Azaheterociclobencilaminas biciclicas como inhibidores de pi3k
WO2015191677A1 (en) 2014-06-11 2015-12-17 Incyte Corporation Bicyclic heteroarylaminoalkyl phenyl derivatives as pi3k inhibitors
CZ306984B6 (cs) 2014-12-15 2017-11-01 Ústav experimentální botaniky AV ČR, v. v. i. 6,8-Disubstituované-9-(heterocyklyl)puriny, přípravky obsahující tyto deriváty a jejich použití v kosmetických a medicínských aplikacích
SG10201907576SA (en) 2015-02-27 2019-09-27 Incyte Corp Salts of pi3k inhibitor and processes for their preparation
US9732097B2 (en) 2015-05-11 2017-08-15 Incyte Corporation Process for the synthesis of a phosphoinositide 3-kinase inhibitor
US9988401B2 (en) 2015-05-11 2018-06-05 Incyte Corporation Crystalline forms of a PI3K inhibitor
CZ307722B6 (cs) * 2015-08-28 2019-03-27 Univerzita PalackĂ©ho v Olomouci Adeninové deriváty a jejich použití
CZ307868B6 (cs) * 2017-04-28 2019-07-10 Univerzita PalackĂ©ho v Olomouci Deriváty 9-(2-oxacykloalkyl)-9H-purin-2,6-diaminu, přípravky obsahující tyto deriváty a jejich použití
SG11202011680YA (en) 2018-06-01 2020-12-30 Incyte Corp Dosing regimen for the treatment of pi3k related disorders
EP4178959B1 (en) 2020-07-13 2025-09-10 Univerzita Palackého v Olomouci Nitrogen heterocyclic cytokinin derivatives, compositions containing these derivatives and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5371089A (en) * 1987-02-26 1994-12-06 Senetek, Plc Method and composition for ameliorating the adverse effects of aging
US5021422A (en) * 1989-06-08 1991-06-04 Senetek Plc Method and composition for treating hyperproliferative skin diseases using 6-aminopurine cytokinins
WO2004037159A2 (en) * 2002-10-23 2004-05-06 Obetherapy Biotechnology Compounds, compositions and methods for modulating fat metabolism
MXPA06002997A (es) * 2003-09-18 2007-02-08 Conforma Therapeutics Corp Novedosos compuestos heterociclicos como inhibidores- hsp90.
CN101217999A (zh) * 2005-07-08 2008-07-09 宝洁公司 用于哺乳动物皮肤和毛发美化的个人护理组合物及方法

Similar Documents

Publication Publication Date Title
JP2009543799A5 (https=)
RU2335493C2 (ru) Производные хинолина в качестве ингибиторов фосфодиэстеразы
JP2018135343A5 (https=)
JP2012508734A5 (https=)
SG10201909122QA (en) Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases
JP2010521514A5 (https=)
JP2012184234A5 (https=)
JP2013534248A5 (https=)
SG10201903512SA (en) Bile Acid Recycling Inhibitors For Treatment Of Pediatric Cholestatic Liver Diseases
JP2011522816A5 (https=)
JP2010265321A5 (https=)
JP2014515013A5 (https=)
JP2013519645A5 (https=)
JP2012500004A5 (https=)
JP2010513224A5 (https=)
JP2016520618A5 (https=)
JP2013541514A5 (https=)
JP2010155827A5 (https=)
JP2009533356A5 (https=)
JP2011527333A5 (https=)
JP2008500999A5 (https=)
JP2010524947A5 (https=)
JP2018537513A5 (https=)
JP2011046708A5 (https=)
JP2013510169A5 (https=)